A woman in her mid-30s has spoken publicly about the strain on her marriage caused by her husband’s use of Mounjaro, a weight-loss medication, highlighting concerns over its impact on relationships and mental health. The couple, who have been together for 12 years and have a four-year-old son, say the drug has not only affected the husband's physical health but also seriously disrupted their family life.

The husband, David, a former insurance company owner now in his late 40s, began taking Mounjaro in mid-2024 after selling his business and experiencing what has been described as an identity crisis. Though his body mass index (BMI) was within a normal range, David sought to lose weight through the medication, which is typically prescribed for people with obesity or related health issues. He reportedly acquired the drug through an online clinic using inaccurate personal information to obtain prescriptions.

Over a period of nearly two years, David lost approximately three stone (around 19 kilograms), transforming his physique from stocky to lean and muscular. However, this physical change has coincided with significant lifestyle and behavioural shifts that his wife describes as detrimental. She reports that he has become obsessive about his diet, withdrawing from family meals and social activities, eating only specially prepared micro-portion meals, and maintaining irregular eating schedules dictated by the drug’s effects.

The wife, who previously battled anorexia during her youth and spent years recovering, likens the presence of Mounjaro pens in their home to an alcoholic keeping alcohol nearby. She describes the drug as triggering her own anxieties and fears about the resurgence of eating disorder tendencies, compounded by her husband's growing obsessions and secretive behaviour. She also alleges that David exhibits signs of an emerging eating disorder himself, including self-induced vomiting after consuming amounts he perceives as excessive.

The couple’s intimate relationship has reportedly suffered, with a total loss of physical affection for over 18 months, diminished libido from the husband's side, and a growing emotional distance. The wife states that previous aspects of her husband's personality—his warmth, kindness, and enjoyment in cooking and socialising—have been replaced with rigidity and control focused on health and weight loss. Despite raising her concerns, she says David has refused to discontinue the medication or engage in discussions about the marriage’s difficulties.

David’s fitness regime expanded beyond the medication, including bootcamp classes and personal training, and he remains devoted to caring for their son, maintaining an attentive parenting role. Nonetheless, his wife expresses deep disappointment and mentions contemplating divorce, citing the drug’s presence as a central factor worsening their relationship.

The wife is also critical of the broader trend she sees in the use of GLP-1 receptor agonists, such as Mounjaro, for non-medical weight loss purposes, arguing that they may contribute to a new wave of eating disorders. She reflects that if these drugs had been available during her own struggle with anorexia, they might have posed a deadly risk.

Experts caution that while weight-loss medications can be effective for certain medical conditions, their off-label or unregulated use may carry mental health risks, particularly for individuals with or vulnerable to eating disorders. The case outlined by this couple underscores concerns about the psychological and social impacts of these drugs beyond mere physical weight changes.